Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric PatientsSima Bhatt, Shalini Shenoy, Lolie C. Yu et al.|Transplantation and Cellular Therapy|2018Cited by 16
HESTER: A Phase II Study Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion in Pediatric and Young Adult Patients with Acute Lymphoblastic Leukemia Experiencing Loss of B-Cell AplasiaMichael W. Boyer, Jennifer Willert, Sonali Chaudhury et al.|Blood|2020Cited by 8
Non-Myeloablative Conditioning Targeting Host Immunosuppression Is Successful in Matched Sibling Donor Stem Cell Transplantation for Hemoglobinopathies in ChildrenAllison A. King, Shalini Shenoy, Nancy Bunin et al.|Blood|2014Cited by 1
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in ChildrenJeffrey J. Bednarski, Shalini Shenoy, Catherine T. Le et al.|Transplantation and Cellular Therapy|2013Cited by 1
ALL-026: Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion Following Loss of B-Cell Aplasia in Pediatric and Young Adult Patients with Acute Lymphoblastic Leukemia: HESTER Phase II StudyMichael W. Boyer, Jennifer Willert, Sonali Chaudhury et al.|Clinical Lymphoma Myeloma & Leukemia|2021Cited by 1